Literature DB >> 10796910

Hepatocellular carcinoma: are combined CT during arterial portography and CT hepatic arteriography in addition to triple-phase helical CT all necessary for preoperative evaluation?

H J Jang1, J H Lim, S J Lee, C K Park, H S Park, Y S Do.   

Abstract

PURPOSE: To determine whether the combination of CT during arterial portography (CTAP) and CT hepatic arteriography (CTHA) provides an added benefit to triple-phase helical CT (THCT) alone in the preoperative evaluation of hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: Fifty-two consecutive patients with pathologically proved HCC underwent THCT (hepatic arterial, portal venous, and delayed phases) and combined CTAP and CTHA. Two radiologists reviewed the images in three sessions: first the THCT images alone, then with the CTAP images, and finally all three sets of images.
RESULTS: There were 73 pathologically confirmed HCCs. Among 72 lesions considered as HCC at THCT, 69 were proved to be HCCs. Of the additional 37 nodules interpreted as HCC at CTAP, only one was confirmed as such. Among the additional 20 lesions presumed to be HCC at combined CTAP and CTHA, only two were proved to be HCCs. The sensitivity was 94% (69 of 73 lesions) at THCT, 96% (70 of 73) with additional CTAP, and 97% (71 of 73) with all three modalities. The positive predictive value was 96% (69 of 72) at THCT, 65% (70 of 107) with additional CTAP, and 80% (71 of 89) with all three modalities.
CONCLUSION: The use of CTAP and CTHA, in addition to being invasive and costly, resulted in an unacceptably high false-positive rate without a substantial increase in sensitivity. Therefore, CTAP and CTHA are not recommended for preoperative evaluation of HCC; THCT alone is preferred.

Entities:  

Mesh:

Year:  2000        PMID: 10796910     DOI: 10.1148/radiology.215.2.r00ma30373

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

1.  Resection of hepatocellular carcinoma without preoperative tumor biopsy.

Authors:  I Levy; P D Greig ; S Gallinger ; B Langer ; M Sherman
Journal:  Ann Surg       Date:  2001-08       Impact factor: 12.969

2.  Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT.

Authors:  J Hwang; S H Kim; M W Lee; J Y Lee
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

Review 3.  Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis.

Authors:  Karen E Bremner; Ahmed M Bayoumi; Morris Sherman; Murray D Krahn
Journal:  Can J Gastroenterol       Date:  2007-08       Impact factor: 3.522

4.  Comparison of gadoxetic acid-enhanced magnetic resonance imaging and contrast-enhanced computed tomography with histopathological examinations for the identification of hepatocellular carcinoma: a multicenter phase III study.

Authors:  Masakatsu Tsurusaki; Keitaro Sofue; Hiroyoshi Isoda; Masahiro Okada; Kazuhiro Kitajima; Takamichi Murakami
Journal:  J Gastroenterol       Date:  2015-07-01       Impact factor: 7.527

5.  Accuracy of multiphasic helical computed tomography and intraoperative sonography in patients undergoing orthotopic liver transplantation for hepatoma: what is the truth?

Authors:  Johannes Zacherl; Peter Pokieser; Fritz Wrba; Christian Scheuba; Rupert Prokesch; Maximilian Zacherl; Friedrich Längle; Gabriela A Berlakovich; Ferdinand Mühlbacher; Rudolf Steininger
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

6.  Outcome of small liver nodules detected by computed tomographic angiography in patients with hepatocellular carcinoma.

Authors:  Hideki Ohnishi; Kohsaku Sakaguchi; Kazuhiro Nouso; Yoshiyuki Kobayashi; Shinichiro Nakamura; Hironori Tanaka; Yasuhiro Miyake; Bon Shoji; Shouta Iwadou; Yasushi Shiratori
Journal:  Hepatol Int       Date:  2010-07-25       Impact factor: 6.047

7.  Gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma: an initial experience.

Authors:  Yulri Park; Seong Hyun Kim; Seung Hoon Kim; Yong Hwan Jeon; Jongmee Lee; Min Ju Kim; Dongil Choi; Won Jae Lee; Heejung Kim; Ji Hyun Koo; Hyo Keun Lim
Journal:  Korean J Radiol       Date:  2010-06-21       Impact factor: 3.500

8.  Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography.

Authors:  Hyo-Sung Kwak; Jeong-Min Lee; Chong-Soo Kim
Journal:  Eur Radiol       Date:  2003-10-03       Impact factor: 5.315

9.  C-arm CT during hepatic arteriography tumour-to-liver contrast: intraindividual comparison of three different contrast media application protocols.

Authors:  Claus Koelblinger; Wolfgang Schima; Vanessa Berger-Kulemann; Florian Wolf; Christina Plank; Michael Weber; Johannes Lammer
Journal:  Eur Radiol       Date:  2012-11-09       Impact factor: 5.315

10.  Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT.

Authors:  Jeong-Min Lee; In-Hwan Kim; Hyo-Sung Kwak; Ji-Hyun Youk; Young-Min Han; Chong-Soo Kim
Journal:  Korean J Radiol       Date:  2003 Jan-Mar       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.